(Q36430258)

14 August 2017

1 reference

title

The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification (English)

1 reference

14 August 2017

Jamie C Mandac

1

1 reference

14 August 2017

Sonal Chaudhry

series ordinal

2

1 reference

14 August 2017

Kenneth E Sherman

series ordinal

3

1 reference

14 August 2017

Yaron Tomer

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

43

1 reference

14 August 2017

4

1 reference

14 August 2017

661-672

1 reference

Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.

14 August 2017

1 reference

Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia

21 January 2018

1 reference

Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia

21 January 2018

1 reference

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

21 January 2018

1 reference

Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.

21 January 2018

1 reference

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

7 January 2021

Interferons: mechanisms of action and clinical applications

1 reference

7 January 2021

Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities

1 reference

7 January 2021

The interferons. Mechanisms of action and clinical applications

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Side effects of therapy for chronic hepatitis C.

1 reference

7 January 2021

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

7 January 2021

PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCER

1 reference

7 January 2021

Interferon-alpha and autoimmune thyroid disease

1 reference

7 January 2021

Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature

1 reference

7 January 2021

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

1 reference

7 January 2021

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

1 reference

7 January 2021

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

1 reference

7 January 2021

Graves' ophthalmopathy associated with interferon-alpha treatment for hepatitis C

1 reference

7 January 2021

Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity

1 reference

7 January 2021

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

1 reference

7 January 2021

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

1 reference

7 January 2021

Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families

1 reference

7 January 2021

Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function

1 reference

7 January 2021

Hepatitis C and thyroid autoimmunity: is there a link?

1 reference

7 January 2021

The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey

1 reference

7 January 2021

Existence of anti-thyroglobulin IgG in healthy subjects

1 reference

7 January 2021

A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay.

1 reference

7 January 2021

Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis

1 reference

7 January 2021

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

7 January 2021

Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

1 reference

7 January 2021

Longitudinal Study of Antibodies against Thyroid in Patients Undergoing Interferon-&alpha; Therapy for HCV Chronic Hepatitis

1 reference

7 January 2021

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy

1 reference

7 January 2021

Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin.

1 reference

7 January 2021

Thyrotropin receptor-associated diseases: from adenomata to Graves disease

1 reference

7 January 2021

Pathogenesis of Graves' ophthalmopathy

1 reference

7 January 2021

Thyroid autoimmunity and dysfunction associated with type I interferon therapy.

1 reference

7 January 2021

Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus

1 reference

7 January 2021

Side effects of high-dose interferon therapy for chronic hepatitis C.

1 reference

7 January 2021

Failure to find an association between hepatitis C virus and thyroid autoimmunity

1 reference

7 January 2021

Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection

1 reference

7 January 2021

Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study

1 reference

7 January 2021

Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy

1 reference

7 January 2021

Thyroid disorders in chronic hepatitis C.

1 reference

7 January 2021

Latent autoimmune thyroid disease in patients with chronic HCV hepatitis

1 reference

7 January 2021

The spectrum of thyroid disease in a community: the Whickham survey

1 reference

7 January 2021

The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism

1 reference

7 January 2021

Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

1 reference

7 January 2021

The genetics of Graves' disease: HLA and disease susceptibility

1 reference

7 January 2021

Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease

1 reference

7 January 2021

The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.

1 reference

7 January 2021

Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus

1 reference

7 January 2021

The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease

1 reference

7 January 2021

Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease

1 reference

7 January 2021

HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C

1 reference

7 January 2021

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

7 January 2021

Hepatitis C serotypes in nonalcoholic and alcoholic patients

1 reference

7 January 2021

Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease

1 reference

7 January 2021

Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain

1 reference

7 January 2021

Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.

1 reference

7 January 2021

Comparative study of hepatitis C virus genotypes 1 and 3 in Salvador, Bahia Brazil

1 reference

7 January 2021

Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study

1 reference

7 January 2021

The role of ribavirin in the combination therapy of hepatitis C virus infection.

1 reference

7 January 2021

Ribavirin upregulates interleukin-12 receptor and induces T cell differentiation towards type 1 in chronic hepatitis C.

1 reference

7 January 2021

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

1 reference

7 January 2021

Biologic responses to IFN-alpha administration in humans

1 reference

7 January 2021

Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection

1 reference

7 January 2021

Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans

1 reference

7 January 2021

Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2.

1 reference

7 January 2021

Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis

1 reference

7 January 2021

Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture

1 reference

7 January 2021

Autoimmune aspects of cytokine and anticytokine therapies

1 reference

7 January 2021

Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells

1 reference

7 January 2021

T helper cell subsets in insulin-dependent diabetes

1 reference

7 January 2021

Type I interferons and T helper development

1 reference

7 January 2021

New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine

1 reference

7 January 2021

Innate and acquired immune system in patients developing interferon-alpha-related autoimmune thyroiditis: a prospective study

1 reference

7 January 2021

Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism

1 reference

7 January 2021

Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease?

1 reference

7 January 2021

The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse

1 reference

7 January 2021

Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.

1 reference

7 January 2021

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21146

1 reference

14 August 2017

1 reference